Results
|
141.
|
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks. [electronic resource] by
- Roberts, J D
- Shibata, S
- Spicer, D V
- McLeod, H L
- Tombes, M B
- Kyle, B
- Carroll, M
- Sheedy, B
- Collier, M A
- Pithavala, Y K
- Paradiso, L J
- Clendeninn, N J
Producer: 20000522
In:
Cancer chemotherapy and pharmacology vol. 45
Availability: No items available.
|
|
142.
|
|
|
143.
|
|
|
144.
|
|
|
145.
|
|
|
146.
|
|
|
147.
|
|
|
148.
|
|
|
149.
|
Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. [electronic resource] by
- Li, Chi-Ming
- Guo, Meirong
- Salas, Martha
- Schupf, Nicole
- Silverman, Wayne
- Zigman, Warren B
- Husain, Sameera
- Warburton, Dorothy
- Thaker, Harshwardhan
- Tycko, Benjamin
Producer: 20060424
In:
BMC medical genetics vol. 7
Availability: No items available.
|
|
150.
|
|
|
151.
|
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter. [electronic resource] by
- Cherian, Christina
- Kugel Desmoulin, Sita
- Wang, Lei
- Polin, Lisa
- White, Kathryn
- Kushner, Juiwanna
- Stout, Mark
- Hou, Zhanjun
- Gangjee, Aleem
- Matherly, Larry H
Producer: 20130613
In:
Cancer chemotherapy and pharmacology vol. 71
Availability: No items available.
|
|
152.
|
|
|
153.
|
|
|
154.
|
|
|
155.
|
|
|
156.
|
|
|
157.
|
|
|
158.
|
|
|
159.
|
10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway. [electronic resource] by
- Marsilje, Thomas H
- Labroli, Marc A
- Hedrick, Michael P
- Jin, Qing
- Desharnais, Joel
- Baker, Stephen J
- Gooljarsingh, Lata T
- Ramcharan, Joseph
- Tavassoli, Ali
- Zhang, Yan
- Wilson, Ian A
- Beardsley, G Peter
- Benkovic, Stephen J
- Boger, Dale L
Producer: 20030731
In:
Bioorganic & medicinal chemistry vol. 10
Availability: No items available.
|
|
160.
|
|